What would you recommend as a subsequent therapy for patients with ROS-1 gene re-arrangement after progression on crizotinib?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · UCSD Moores Cancer Center
Answered on
Clinical trial (entrectinib, repotrectinib) or lorlatinib
Join for free or sign in to see the full answer